| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |